SAN RAFAEL, Calif., July 23, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, August 5, 2024, at 4:30 p.m. ET to discuss second quarter 2024 financial results and provide a general business update. Contacts: Investors Media Traci McCarty Marni Kottle BioMarin Pharmaceutical Inc.BioMarin Pharmaceutical Inc. (415) 455-7558 (650) 374-2803 Dial-in Number U.S ...